Toxicogenomics: A 2020 Vision
Open accessThe DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
Toxicogenomics (TGx) has contributed significantly to toxicology and now has great potential to support moves towards animal-free approaches in regulatory decision making. Here, we discuss in vitro TGx systems and their potential impact on risk assessment. We raise awareness of the rapid advancement of genomics technologies, which generates novel genomics features essential for enhanced risk assessment. We specifically emphasize the importance of reproducibility in utilizing TGx in the regulatory setting. We also highlight the role of machine learning (particularly deep learning) in developing TGx-based predictive models. Lastly, we touch on the topics of how TGx approaches could facilitate adverse outcome pathways (AOP) development and enhance read-across strategies to further regulatory application. Finally, we summarize current efforts to develop TGx for risk assessment and set out remaining challenges.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A survey on deep learning in medical image analysis
Litjens, G., Kooi, T., Bejnordi, B. E., Setio, A. A. A., Ciompi, F., Ghafoorian, M., van der Laak, J. A. W. M., van Ginneken, B., & Sánchez, C. I. (2017) · Medical Image Analysis · doi:10.1016/j.media.2017.07.005 · Cited by 15,332
A manifesto for reproducible science
Munafò, M. R., Nosek, B. A., Bishop, D. V. M., Button, K. S., Chambers, C. D., Percie du Sert, N., Simonsohn, U., Wagenmakers, E.-J., Ware, J. J., & Ioannidis, J. P. A. (2017) · Nature Human Behaviour · doi:10.1038/s41562-016-0021 · Cited by 3,397
Context-dependent pre-trained deep neural networks for large-vocabulary speech recognition
Dahl, G. E., Yu, D., Deng, L., & Acero, A. (2012) · IEEE Transactions on Audio Speech and Language Processing · doi:10.1109/tasl.2011.2134090 · Cited by 3,011 · cited 1×
“Transfer learning is widely applied in image analysis [41] and automatic speech recognition [42], but has not been investigated in TGx.”
BackgroundMAQC Consortium, Shi, L., Shi, L., Reid, L. H., Jones, W. D., Shippy, R., Warrington, J. A., Baker, S. C., Collins, P. J., de Longueville, F., et al. (2006) · Nature Biotechnology · doi:10.1038/nbt1239 · Cited by 2,126 · cited 1×
“However, a general rule can be followed, as suggested by the FDA-led MicroArray Quality Control (MAQC) consortium, to determine a reproducible DEG profile: ranking the genes by fold-change by comparing the treated with the control condition, followed by removing these genes with poor statistics (measured by a nonstrin…”
Self-citationOrganoids as an in vitro model of human development and disease
Fatehullah, A., Tan, S. H., & Barker, N. (2016) · Nature Cell Biology · doi:10.1038/ncb3312 · Cited by 1,508 · cited 1×
“Unable to mimic in vivo growth factor Limited use in modeling inflammatory responses of tissues [57]”
BackgroundDeepTox: toxicity prediction using deep learning
Mayr, A., Klambauer, G., Unterthiner, T., & Hochreiter, S. (2016) · Frontiers in Environmental Science · doi:10.3389/fenvs.2015.00080 · Cited by 1,081 · cited 1×
“As more and more TGx data is generated and becomes available in the near future, AI, particularly deep learning, will play an increasing role in toxicology, specifically for TGx [37].”
BackgroundA Human Disease Model of Drug Toxicity–Induced Pulmonary Edema in a Lung-on-a-Chip Microdevice
Huh, D., Leslie, D. C., Matthews, B. D., Fraser, J. P., Jurek, S., Hamilton, G. A., Thorneloe, K. S., McAlexander, M. A., & Ingber, D. E. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004249 · Cited by 993 · cited 1×
“technologies, including organ-on-a-chip [49], 3D-printed tissues [50], and nanoparticle techniques [51], are used increasingly in toxicology.”
MethodSEQC/MAQC-III Consortium (2014) · Nature Biotechnology · doi:10.1038/nbt.2957 · Cited by 983
Self-citationMAQC Consortium (2010) · Nature Biotechnology · doi:10.1038/nbt.1665 · Cited by 889
Bell, C. C., Hendriks, D. F. G., Moro, S. M. L., Ellis, E., Walsh, J., Renblom, A., Fredriksson Puigvert, L., Dankers, A. C. A., Jacobs, F., Snoeys, J., et al. (2016) · Scientific Reports · doi:10.1038/srep25187 · Cited by 739 · cited 2×
“TGx has been adopted for developing organ toxicity-related AOP, such as neurotoxicity [58] and fatty liver diseases [45].”
Method
Cited by
Domingues, C., Santos, A., Alvarez-Lorenzo, C., Concheiro, A., Jarak, I., Veiga, F., Barbosa, I., Dourado, M., & Figueiras, A. (2022) · ACS Nano · doi:10.1021/acsnano.2c00128 · Cited by 235
Callegaro, G., Kunnen, S. J., Trairatphisan, P., Grosdidier, S., Niemeijer, M., den Hollander, W., Guney, E., Piñero Gonzalez, J., Furlong, L., Webster, Y. W., et al. (2021) · Archives of Toxicology · doi:10.1007/s00204-021-03141-w · Cited by 43
Arnesdotter, E., Rogiers, V., Vanhaecke, T., & Vinken, M. (2021) · Critical Reviews in Toxicology · doi:10.1080/10408444.2021.1931027 · Cited by 27
Metadata
- Authors
- Liu, Z., Huang, R., Roberts, R., & Tong, W.
- Venue
- Trends in Pharmacological Sciences
- Publisher
- Elsevier BV
- Published
- 2019-02
- Volume
- 40
- Issue
- 2
- Pages
- 92-103
- ISSN
- 0165-6147 (ISSN-L)
- OpenAlex
- W2906393572
- Cited by
- 123
- References
- 15
- FWCI
- 1.17
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Toxicogenomics: A 2020 Vision. https://app.cochat.ai/papers/10.1016/j.tips.2018.12.001
- The paper
- Liu, Z., Huang, R., Roberts, R., & Tong, W. (2019). Toxicogenomics: A 2020 Vision. Trends in Pharmacological Sciences. https://doi.org/10.1016/j.tips.2018.12.001
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.